Risks of anticholinergic drugs

Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention.

Two recent papers using large electronic health records have explored the impact of drugs with anticholinergic properties.

The first, “Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease” view here used a HealthFacts database (Cerner Corporation, Kansas City, Missouri, USA) composed of 16,302 patients with Parkinson disease.

The second “Anticholinergic drugs and risk of dementia: case-control study” view here utilized 14,453 patients with dementia and 86,403 controls from the UK Clinical Practice Research Datalink.

Both studies observed a robust relationship between the use of drugs with anticholinergic properties and adverse consequences, including dementia, increased risks of visit to emergency departments and risk of fracture.  Both studies demonstrate the importance of large electronic health record systems in understanding adverse drug events.

Posted in

More RSI News

Emma Hartnett 2018 recipient of Center for Produce Safety (CPS) Research Award

October 11, 2018
RSI logo in white

CPS has recently announced 13 new research awards totaling a little over $2.6 million. The awards are for research projects directed at answering critical questions…

Read News Item

Best Practices for Consideration of the Effects of Climate Change in Project-Level Assessments

May 4, 2018
RSI logo in white

Risk Sciences International (RSI) is pleased to announce in collaboration with the Ontario Centre for Climate Impacts and Adaptation Resources (OCCIAR), the public release of…

Read News Item

Risks of anticholinergic drugs

May 2, 2018
RSI logo in white

Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention. Two recent papers using large electronic health records…

Read News Item

Dr. Emma Hartnett Selected for JEMRA Roster of Scientific Experts

April 19, 2018
RSI logo in white

RSI’s Emma Hartnett has been selected to be part of the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (JEMRA) Roster of Experts for a…

Read News Item